The department’s director, Shelley Rouillard, said her unit “thoroughly examined this merger and determined enrollees will have continued access to appropriate healthcare services and also imposed conditions that will help increase access and quality of care, remove barriers to care and improve health outcomes.”
The department approved the deal on the condition that CVS and Aetna will not increase health insurance premiums due to acquisition expenses. CVS and Aetna also agreed to keep premium rate increases to a minimum. In addition, the companies agreed to invest almost $240 million in California’s healthcare system.
In August, California’s insurance commissioner asked the Department of Justice to sue to block CVS’ takeover of Aetna. However, in October CVS entered into an agreement with the Department of Justice to move forward with the acquisition, with the caveat Aetna would sell its stand-alone Medicare Part D prescription drug plans to Tampa, Fla.-based WellCare Health Plans. WellCare will assume control of the 2.2 million-member business Dec. 31, assuaging any antitrust concerns from the department.
More articles on healthcare industry transactions:
Bankrupt Mississippi hospital receives takeover bid
CHS to divest 2 South Carolina hospitals by Dec. 31
HCA merges 2 Florida hospitals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.